Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules in hypoxic tissue refer to the proteins, nucleic acids, and lipids within cells that are affected by low oxygen levels. Hypoxia leads to significant changes in cellular metabolism, gene expression, and survival strategies, often mediated by hypoxia-inducible factors (HIFs). This condition is prevalent in diseases like cancer, where it contributes to tumor progression and therapeutic resistance.
Inhibition of HIF-1α degradation, modulation of angiogenesis, induction of anaerobic glycolysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules in hypoxic tissue.